Condensed Consolidated Balance Sheets (USD $) In Thousands, unless otherwise specified	Jun. 30, 2014	Dec. 31, 2013
Current assets:
Cash and cash equivalents	$ 64	$ 267
Accounts receivable	149	295
Prepaid expenses and other current assets	67	107
Total current assets	280	669
Property and equipment, net	2	5
Goodwill	3,418	3,418
Patents and other intangible assets, net	1,076	1,213
Other long-term assets	20	0
Total assets	4,796	5,305
Current liabilities:
Accounts payable	435	236
Accrued expenses	461	291
Deferred revenues and customer prepayments	1,689	2,252
Notes payable	50	56
Derivative financial instruments - warrants	40	620
Derivative financial instruments - Series C and D preferred stock and debentures payable	51	296
Debentures payable - carried at fair value	34,942	38,250
Total current liabilities	37,668	42,001
Commitments and contingencies
Preferred stock	4,945	5,164
Shareholders' deficit:
Common stock, no par value, 7,500,000,000 shares authorized, 488,057,870 and 332,321,819 shares issued and outstanding as of June 30, 2014 and December 31, 2013, respectively	4,985	4,985
Additional paid in capital	191,400	190,946
Accumulated deficit	(233,321)	(236,910)
Accumulated other comprehensive loss	(102)	(102)
Treasury stock, at cost, 2,012 shares of common stock	(779)	(779)
Total shareholders' deficit	(37,817)	(41,860)
Total liabilities and shareholders' deficit	4,796	5,305
Series C Convertible Preferred Stock [Member]
Current liabilities:
Derivative financial instruments - Series C and D preferred stock and debentures payable	48	276
Preferred stock	4,597	4,816
Series D Convertible Preferred Stock [Member]
Current liabilities:
Derivative financial instruments - Series C and D preferred stock and debentures payable	3	20
Preferred stock	$ 348	$ 348